Topical Non-Steroidal Anti-Inflammatory Drugs Market Growth Projection by 2029

Nonsteroidal anti-inflammatory drugs (NSAIDs) are creams, gels, rubs, solutions, or sprays that include a nonsteroidal anti-inflammatory agent and are designed to be administered directly to the skin overlaying a painful joint or bone area. They're used to treat arthritic symptoms including inflammation, edema, and stiffness and decrease pain. Topical nonsteroidal anti-inflammatory drugs (NSAIDs) can also be used to treat actinic keratosis (a precancerous patch of thick, scaly or crusted skin).

NSAIDs are commonly used to treat pain associated with a range of illnesses, including arthritic conditions, but their effectiveness is sometimes restricted by dose-dependent adverse events (AEs) such as gastrointestinal disturbances, cardiovascular events, and renal toxicity. The use of topical formulations, which have the ability to provide analgesic doses locally, at the site of inflammation, while limiting systemic concentrations, could lessen the risk of such side effects. Diclofenac sodium 1.5 percent topical solution (including dimethyl sulfoxide as a penetration enhancer), diclofenac sodium gel 1 percent, and a diclofenac hydroxyethylpyrrolidine 1.3 percent patch are the only topical treatments currently approved in the United States.

Data Bridge Market Research analyses that the topical non-steroidal anti-inflammatory drugs market was valued at USD 2,517.73 million in 2021 and is expected to reach USD 3,776.90 million by 2029, registering a CAGR of 5.20% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Read Full Report Summary @ https://www.databridgemarketresearch.com/reports/global-topical-non-steroidal-anti-inflammatory-drugs-market

North America dominates the topical non-steroidal anti-inflammatory drugs market because of the growing number of research and development activities and presence of major key players in this region. Additionally the rising healthcare expenditure will further propel the market's growth rate in this region.

Asia-Pacific is expected to grow during the forecast period due to surging government awareness programs and the increasing geriatric population in this region. Also, the development of healthcare infrastructure and the increasing number of generic drugs will further propel themarket's growth rate in this region.

Some of the major players operating in the topical non-steroidal anti-inflammatory drugs market are:

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:- corporatesales@databridgemarketresearch.com

Article source: https://article-realm.com/article/Sports-Recreation/42624-Topical-Non-Steroidal-Anti-Inflammatory-Drugs-Market-Growth-Projection-by-2029.html